Oncoprint analysis of the Foundation Medicine dataset also showed that BRCA1 and BRCA2 mutations, and germline and somatic mutations, were mutually exclusive in ovarian cancer and breast cancer (Supplementary Fig. 4). Here, BRCA2 is linked to ovarian cancer.